Luke Evnin is Director at Werewolf Therapeutics, Inc. (HOWL). They have made 33 open-market trades across 14 companies since 2005, most recently 2026-07-07.
CIK 0001134657
12 open-market purchases totalling $37.2M since 2007, against 21 sales. Across 11 scored buys the stock is up 5.6% at ninety days, and 3.2 points ahead of the S&P over the same stretch.
11 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 18% | 45% | 45% |
| Avg Move | -15.0% | -5.2% | +5.6% |
| Alpha | -12.9% | -6.4% | +3.2% |
| Scored | 11 | 11 | 11 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 44% | 22% | 22% |
| Avg Move | -0.6% | +10.1% | +26.4% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HOWL | SELL · 10b5-1 | 2026-07-06 | 2026-07-08 | $0.31 | $45K | +0.6% | +10.7% | +156.7% |
| HOWL | SELL · 10b5-1 | 2026-06-29 | 2026-06-29 | $0.30 | $47K | +29.5% | +48.4% | +196.8% |
| HOWL | SELL · 10b5-1 | 2026-06-09 | 2026-06-10 | $0.37 | $28K | +0.5% | +11.2% | +166.9% |
| HOWL | SELL · 10b5-1 | 2026-06-04 | 2026-06-08 | $0.41 | $43K | -7.1% | -6.5% | +154.0% |
| HOWL | SELL · 10b5-1 | 2026-06-01 | 2026-06-03 | $0.46 | $64K | -12.4% | -27.5% | +116.3% |
| HOWL | SELL · 10b5-1 | 2026-05-27 | 2026-05-29 | $0.47 | $66K | -20.2% | -34.5% | +110.8% |
| HOWL | SELL · 10b5-1 | 2026-05-21 | 2026-05-26 | $0.45 | $87K | -17.7% | -29.2% | +86.8% |
| HOWL | SELL · 10b5-1 | 2026-05-18 | 2026-05-20 | $0.45 | $76K | +3.6% | -10.5% | -1.7% |
| HOWL | SELL · 10b5-1 | 2026-05-13 | 2026-05-13 | $0.54 | $24K | -17.3% | -29.9% | -31.7% |
| HOWL | SELL · 10b5-1 | 2026-05-08 | 2026-05-12 | $0.69 | $280K | -22.2% | -32.1% | -32.8% |
| HOWL | SELL · 10b5-1 | 2026-05-05 | 2026-05-07 | $0.64 | $64K | -36.9% | -44.2% | -40.5% |
| HOWL | SELL · 10b5-1 | 2026-04-30 | 2026-05-04 | $0.72 | $198K | -19.5% | -36.8% | -45.4% |
| HOWL | SELL · 10b5-1 | 2026-04-27 | 2026-04-29 | $0.75 | $155K | -6.0% | -36.2% | -36.2% |
| HOWL | SELL · 10b5-1 | 2026-01-16 | 2026-01-20 | $0.54 | $21K | +14.8% | +24.8% | +64.8% |
| HOWL | SELL | 2026-01-13 | 2026-01-15 | $0.56 | $62K | +32.1% | +22.0% | +75.9% |
| HOWL | SELL | 2026-01-08 | 2026-01-12 | $0.59 | $54K | +18.4% | +17.8% | +60.4% |
| HOWL | SELL | 2026-01-05 | 2026-01-07 | $0.65 | $46K | -10.0% | -2.4% | +60.2% |
| HOWL | SELL | 2025-12-30 | 2026-01-02 | $0.62 | $48K | -8.9% | +5.7% | +55.0% |
| HOWL | SELL · 10b5-1 | 2025-12-22 | 2025-12-29 | $0.63 | $251K | -4.2% | +13.3% | +26.1% |
| HOWL | SELL · 10b5-1 | 2025-12-15 | 2025-12-17 | $1.08 | $52K | -23.6% | -31.3% | +8.6% |
| HOWL | SELL · 10b5-1 | 2025-12-10 | 2025-12-12 | $1.07 | $89K | -40.0% | -47.8% | -24.9% |
| HOWL | SELL · 10b5-1 | 2025-12-05 | 2025-12-09 | $1.00 | $95K | -32.0% | -37.6% | -27.5% |
| HOWL | SELL · 10b5-1 | 2025-12-02 | 2025-12-04 | $0.93 | $169K | +11.0% | -33.8% | -37.1% |
| HOWL | SELL · 10b5-1 | 2025-11-26 | 2025-12-01 | $0.96 | $88K | +21.1% | -29.6% | -35.2% |
| HOWL | SELL · 10b5-1 | 2025-11-21 | 2025-11-25 | $0.94 | $171K | +6.4% | -30.4% | -29.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| ETRM | 1,588,033 | $3.3M |
| CERC | 595,436 | $1.7M |
| MBRX | 4,814,725 | $1.4M |
| PCRX | 20,311 | $738K |
| ONCR | 1,641,169 | $198K |
| HOWL | 107,429 | $106K |
| CRTX | 7,226 | $14K |
| ZLCS | 12,935,885 | — |
| HEM | 3,828,319 | — |
| OMRI | 60,640 | — |
| OSCI | 2,272,935 | — |
| REST | 1,861,934 | — |
| SOMX | 4,632,562 | — |
| TMPM | 415,500 | — |
| VRUS | 2,089,394 | — |
| Total | $258.6M |
Shares reported on the most recent Form 4, priced at the 2026-07-08 close. 8 holdings could not be priced and are excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Scored | 9 | 9 | 9 |